{"id":427,"date":"2021-10-07T15:35:49","date_gmt":"2021-10-07T15:35:49","guid":{"rendered":"http:\/\/apogee-biotech.com\/?p=427"},"modified":"2021-10-07T15:35:49","modified_gmt":"2021-10-07T15:35:49","slug":"analysis-of-phase-2-3-data-including-a-62-reduction-in-mortality-with-oral-opaganib-in-moderately-severe-covid-19-patients","status":"publish","type":"post","link":"http:\/\/apogee-biotech.com\/index.php\/analysis-of-phase-2-3-data-including-a-62-reduction-in-mortality-with-oral-opaganib-in-moderately-severe-covid-19-patients\/","title":{"rendered":"Analysis of Phase 2\/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 Patients"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.redhillbio.com\/news\/news-details\/2021\/RedHill-Biopharma-Reports-Further-Analysis-of-Phase-23-Data-Including-a-62-Reduction-in-Mortality-with-Oral-Opaganib-in-Moderately-Severe-COVID-19-Patients\/default.aspx\">https:\/\/www.redhillbio.com\/news\/news-details\/2021\/RedHill-Biopharma-Reports-Further-Analysis-of-Phase-23-Data-Including-a-62-Reduction-in-Mortality-with-Oral-Opaganib-in-Moderately-Severe-COVID-19-Patients\/default.aspx<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>https:\/\/www.redhillbio.com\/news\/news-details\/2021\/RedHill-Biopharma-Reports-Further-Analysis-of-Phase-23-Data-Including-a-62-Reduction-in-Mortality-with-Oral-Opaganib-in-Moderately-Severe-COVID-19-Patients\/default.aspx<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/apogee-biotech.com\/index.php\/wp-json\/wp\/v2\/posts\/427"}],"collection":[{"href":"http:\/\/apogee-biotech.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/apogee-biotech.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/apogee-biotech.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/apogee-biotech.com\/index.php\/wp-json\/wp\/v2\/comments?post=427"}],"version-history":[{"count":2,"href":"http:\/\/apogee-biotech.com\/index.php\/wp-json\/wp\/v2\/posts\/427\/revisions"}],"predecessor-version":[{"id":429,"href":"http:\/\/apogee-biotech.com\/index.php\/wp-json\/wp\/v2\/posts\/427\/revisions\/429"}],"wp:attachment":[{"href":"http:\/\/apogee-biotech.com\/index.php\/wp-json\/wp\/v2\/media?parent=427"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/apogee-biotech.com\/index.php\/wp-json\/wp\/v2\/categories?post=427"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/apogee-biotech.com\/index.php\/wp-json\/wp\/v2\/tags?post=427"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}